Abstract | OBJECTIVE: METHODS: AIA was induced in female Lewis rats. Arthritis was assessed by hindpaw swelling. TNF-a, IL-1beta, and IL-6 levels in paw extracts were determined by ELISA. To assess the effects on cytokine levels, rats were treated prophylactically with FK506 (3 mg/kg) or MTX (0.1 mg/kg) from day 1 to day 17, and therapeutically with FK506 (5 mg/kg) or MTX (1 mg/kg) from day 15 to day 17 (3-day treatment) or day 15 to 20 (6-day treatment) by oral administration. RESULTS: TNF-a, IL-1beta, and IL-6 levels in paw tissue were found to significantly increase between day 15 and day 21 after adjuvant injection, when the arthritis was in a developed stage. Prophylactic treatment with FK506 and MTX suppressed arthritis and reduced the levels of those inflammatory cytokines. FK506 caused a marked reduction of TNF-a and IL-1beta levels in paw tissue even in short-term (3-day) therapeutic treatment. It reduced all levels of TNF-a, IL-1beta, and IL-6 in paws in 6-day therapeutic treatment. In contrast, therapeutic treatment with MTX affected neither TNF-a or IL-6 levels in paws. MTX reduced IL-1beta levels only in the 6-day treatment. CONCLUSION:
FK506 is more effective than MTX in reducing elevated levels of inflammatory cytokines TNF-a, IL-1beta, and IL-6 in established stages of AIA. Our findings suggest that inhibition of T cell activation results in a rapid reduction of inflammatory cytokine levels even after the arthritis is established in AIA.
|
Authors | Katsue Magari, Susumu Miyata, Fusako Nishigaki, Yoshitaka Ohkubo, Seitaro Mutoh, Toshio Goto |
Journal | The Journal of rheumatology
(J Rheumatol)
Vol. 30
Issue 10
Pg. 2193-200
(Oct 2003)
ISSN: 0315-162X [Print] Canada |
PMID | 14528517
(Publication Type: Journal Article)
|
Chemical References |
- Cytokines
- Immunosuppressive Agents
- Interleukin-1
- Interleukin-6
- Tumor Necrosis Factor-alpha
- Tacrolimus
- Methotrexate
|
Topics |
- Animals
- Arthritis, Experimental
(drug therapy, metabolism, pathology)
- Cytokines
(metabolism)
- Disease Models, Animal
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Edema
(drug therapy, pathology)
- Enzyme-Linked Immunosorbent Assay
- Female
- Hindlimb
(drug effects, metabolism, pathology)
- Immunosuppressive Agents
(administration & dosage, therapeutic use)
- Interleukin-1
(metabolism)
- Interleukin-6
(metabolism)
- Methotrexate
(administration & dosage, therapeutic use)
- Rats
- Rats, Inbred Lew
- Tacrolimus
(administration & dosage, therapeutic use)
- Tumor Necrosis Factor-alpha
(analysis)
|